Showing results (81-90 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|November 19, 2025
Use of Potentially Inappropriate Medication and Association with Falls During Hospitalisation: An Analysis Based on Electronic Health Records (POLAR_MI project)Louisa Redeker, Miriam Kesselmeier, Beate Mussawy, et al.
Drugs - Real World Outcomes|January 12, 2026
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)Pilar Escribano Subias, Murali M Chakinala, Kelly M Chin, et al.
Drugs - Real World Outcomes|October 13, 2025
Retention Rates of Biological Drugs in Spondyloarthritis: A 24-Month Observational Study in Patients Aged 60 Years or OlderRoberta Foti, Francesco De Lucia, Giorgio Amato, et al.
Drugs - Real World Outcomes|October 3, 2025
Persistence of Weekly Injectable Semaglutide Use in Patients with Diabetes Mellitus and Obesity: A Retrospective Follow-Up in ColombiaManuel Enrique Machado-Duque, Andrés Gaviria-Mendoza, Luis Fernando Valladales-Restrepo, et al.
Drugs - Real World Outcomes|September 17, 2021
European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record ReviewRiyaz Shah, Nicolas Girard, Saurabh P Nagar, et al.
Drugs - Real World Outcomes|April 20, 2020
Potentially Inappropriate Medication Use in Older Adults in the Preoperative Period: A Retrospective Study of a Noncardiac Surgery CohortMarie-France Forget, Emily Gibson McDonald, Astrid Bicamumpaka Shema, et al.
Drugs - Real World Outcomes|May 23, 2021
Factors Associated with Hyponatremia in Patients Newly Prescribed Citalopram: A Retrospective Observational StudyAndrea Christine Shysh, Zahinoor Ismail, Davinder Sidhu, et al.
Drugs - Real World Outcomes|April 30, 2021
Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT® Autoinjector: A Retrospective Cohort StudyOisín Butler, Simone Heeg, Katsiaryna Holl, et al.
Drugs - Real World Outcomes|January 28, 2025
Lipid-Lowering Efficiency and Safety of Alirocumab 300 mg Using a 2-mL Autoinjector Device in Real-World Practice: The MARS StudyKlaus G Parhofer, Peter Bramlage, Constanze Gries, et al.
Drugs - Real World Outcomes|January 19, 2025
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USAManish K Jha, Maryia Zhdanava, Aditi Shah, et al.
Pageof 55